SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CTSI - CABG Minimally Invasive
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pierre Borczuk who wrote (2)8/28/1996 8:08:00 PM
From: Robert Salasidis   of 29
 
I am an Intensive care surgeon at the Montreal General Hospital. One of our CV surgeons is using the device and has done several to date (this is how I initially heard about the company). His success to date has been good. Only one of the patients (out of about 5-6) needed to be converted to a traditional open procedure.

Unfortunately I heard about the company too soon, and bought at 20$. However I think that as more surgeons hear about this, and more ORs are done the stock will likely respond appropriately.

HeartPort is also in the same business, but their technique requires the use of percutaneous bypass. This is more involved surgery, but also allows more than a single LAD bypass. Therefore they are less competing, but more parallel techniques.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News